Beyond Pills: Your Guide to Drug-Free Neuromodulation for Migraine


Key Questions
  • How is neuromodulation used to treat the symptoms of migraine disease?
  • Can neuromodulation prevent as well as treat migraine attacks?
  • Do health insurance providers in the U.S. generally cover the costs of these devices?
  • Are neuromodulation devices challenging for patients to use?
  • Which devices are cleared for children or adolescents?
  • Are these devices safe for use while a person is pregnant or breastfeeding?
  • Who should avoid these devices for safety reasons?
  • When should a clinician consider recommending neuromodulation as a treatment?
  • What kind of results can patients expect?
  • If one neuromodulation device isn’t effective, should a patient try a different one?
Interview Notes
Treatments Mentioned
  • CEFALY
  • CGRP monoclonal antibodies (mAbs)
  • gammaCore
  • HeadaTerm 2
  • Nerivio
  • Neuromodulation devices
  • Occipital nerve implantable stimulators
  • Relivion
  • SAVI Dual (sTMS by eNeura)
  • TENS (transcutaneous electrical nerve stimulation) units
  • Truvaga

For Additional Links and Resources, click here.

Disclaimer: The Migraine World Summit aims to bring you a variety of perspectives and expertise, free from bias or judgment. Alternative theories presented in this video have not been medically reviewed. Views expressed in this interview do not necessarily represent the views of the Migraine World Summit. Please always consult your health care professional and do your own research before making changes to your treatment plan.

Stewart Tepper, MD, FAHS

Vice President
The New England Institute for Neurology and Headache

Stewart Tepper, MD, FAHS, is vice president of the New England Institute for Neurology and Headache (NEINH) in Stamford, Connecticut, and professor of neurology at the Geisel School of Medicine at Dartmouth in Hanover, New Hampshire.

Dr. Tepper has published more than 520 peer-reviewed articles, online features, chapters, and books on headache medicine. He serves on the executive board of directors for the American Headache Society and on the governance committee of the American Migraine Foundation.

Unlock the full 2026 Summit experience:

  • Complete, unedited expert interviews
  • Additional clinical detail beyond the 30-minute live sessions
  • Revisit any 2026 session anytime
  • Transcripts and audio downloads included
View Access Options

Related Talks for: Day 7 (2026)

Brain Fog & Dementia: The Science on the Cognitive Impacts of Migraine

Laura (Libby) Sebrow, PhD

How Behavioral Therapies Help Prevent & Manage Migraine

Paul R. Martin, PhD

Scents, Chemicals & the Migraine Brain

Gudrun Gossrau, MD

Migraine & Headache Australia is the only organization in Australia that has supported the more than 5 million Australians affected by headache and migraine for 20 years. Migraine & Headache Australia is a division of the Brain Foundation.

Learn more

View more/less

Leave a comment


Back to top

Loading...